1-3 of 3
Robert Preissner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P1-11-13: DE-REAL: ITALIAN MULTICENTER EXPERIENCE OF TRASTUZUMAB DERUXTECAN IN A REAL WORLD SETTING

Free
Andrea Botticelli, Simone Scagnoli, Simona Pisegna, Daniele Santini, Antonella Palazzo, Roberta Scafetta, Luigi Rossi, Michelino de Laurentiis, Roberta Caputo, Annarita Verrazzo, Rossana Berardi, Vittoria Barberi, Domenico Bilancia, Giuliana D’auria, Daniele Alesini, Michela Palleschi, Agnese Fabbri, Lidia Strigari, Robert Preissner, Paolo Marchetti, Alessandra Fabi
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P1-11-13.
https://doi.org/10.1158/1538-7445.SABCS22-P1-11-13
Published: 01 March 2023
View article titled, Abstract P1-11-13: DE-REAL: ITALIAN MULTICENTER EXPERIENCE OF TRASTUZUMAB DERUXTECAN IN A REAL WORLD SETTING
Journal Articles

Mimotope optimization for GD2 directed anti-neuroblastoma immunotherapy

Free
Matthias Bleeke, Stefan Fest, Nicole Huebener, Christiane Landgraf, Rudolf Volkmer, Gerhard Gaedicke, Elke Michalsky, Ines Jaeger, Robert Preissner, Holger Lode
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 5101.
Published: 01 May 2007
View article titled, Mimotope optimization for GD2 directed anti-neuroblastoma immunotherapy
Journal Articles

Characterization of GD2 Peptide Mimotope DNA Vaccines Effective against Spontaneous Neuroblastoma Metastases

Free
Stefan Fest, Nicole Huebener, Silke Weixler, Matthias Bleeke, Yan Zeng, Anne Strandsby, Rudolf Volkmer-Engert, Christiane Landgraf, Gerhard Gaedicke, Angelika B. Riemer, Elke Michalsky, Ines S. Jaeger, Robert Preissner, Elisabeth Förster-Wald, Erika Jensen-Jarolim, Holger N. Lode
Journal: Cancer Research
Cancer Res (2006) 66 (21): 10567–10575.
https://doi.org/10.1158/0008-5472.CAN-06-1158
Published: 01 November 2006
View article titled, Characterization of GD2 Peptide Mimotope DNA Vaccines Effective against Spontaneous Neuroblastoma Metastases
Open the PDF for Characterization of GD2 Peptide Mimotope DNA Vaccines Effective against Spontaneous Neuroblastoma Metastases in another window